1. Opinion of the State Council on The Reform of Evaluation and Approval System for Drug and Medical Device. No. 44 Document. August 25, 2015, General Office of the State Council, China.
2. CFDA Town Hall DIA annual meeting, Chicago, June 18–22, 2017.
3. The Opinion on Deepening the Reform of the Review and Approval System and Encouraging the Innovation of Drugs and Medical Devices. October 2017, China General Office of the Communist Party and General Office of the State Council, China.
4. CFDA Decision on Adjusting the Management of Import Drugs Registration. October 10, 2017, CFDA, China. http://eng.sfda.gov.cn/WS03/CL0755/. Accessed May 30, 2018.
5. Protection of Drug Clinical Trial Data. http://samr.cfda.gov.cn/WS01/CL1843/. Accessed June 12, 2018.